Viewing Study NCT03575793


Ignite Creation Date: 2025-12-25 @ 12:58 AM
Ignite Modification Date: 2025-12-25 @ 11:12 PM
Study NCT ID: NCT03575793
Status: COMPLETED
Last Update Posted: 2024-11-12
First Post: 2018-06-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
Sponsor: Salma Sabbour
Organization: